Skip to main content
. 2006 Feb;22(Suppl B):41B–55B. doi: 10.1016/s0828-282x(06)70986-2

Figure 6).

Figure 6)

Antiproliferative effects of sirolimus. 4E-BP1 Eukaryotic initiation factor 4E binding protein; CDK Cyclin-dependent kinase; eIF-4E Eukaryotic initiation factor 4E; FKBP12 FK506 binding protein, 12 kDa; mTOR Mammalian target of rapamycin; PI3K Phosphatidylinositol 3-kinase